Loading...
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with darbepoetin alfa: The trial to reduce cardiovascular events with aranesp therapy (TREAT) experience
Skali, Hicham Parving, Hans Henrik Parfrey, Patrick Burdmann, Emmanuel A. Lewis, E. F. Ivanovich, Peter Keithi-Reddy, Sai Ram McGill, Janet B. McMurray, John Singh, Ajay K.
Skali, Hicham
Parving, Hans Henrik
Parfrey, Patrick
Burdmann, Emmanuel A.
Lewis, E. F.
Ivanovich, Peter
Keithi-Reddy, Sai Ram
McGill, Janet B.
McMurray, John
Singh, Ajay K.
Abstract
More strokes were observed in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) among patients assigned to darbepoetin alfa. We sought to identify baseline characteristics and postrandomization factors that might explain this association.
Keywords
anemia, diabetes melllitus, kidney diseases, erythropoietin, risk, stroke
Date
2011
Type
Journal article
Journal
Circulation
Book
Volume
124
Issue
25
Page Range
2903-2908
Article Number
ACU Department
Collections
Relation URI
Source URL
Event URL
Open Access Status
Open access
License
File Access
Controlled